GB953107A - Veterinary compositions comprising 6?-methyl-17?-hydroxyprogesterone 17-acetate - Google Patents
Veterinary compositions comprising 6?-methyl-17?-hydroxyprogesterone 17-acetateInfo
- Publication number
- GB953107A GB953107A GB25507/60A GB2550760A GB953107A GB 953107 A GB953107 A GB 953107A GB 25507/60 A GB25507/60 A GB 25507/60A GB 2550760 A GB2550760 A GB 2550760A GB 953107 A GB953107 A GB 953107A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- steroid
- estradiol
- mixes
- acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000003431 steroids Chemical class 0.000 abstract 3
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 abstract 2
- 239000002934 diuretic Substances 0.000 abstract 2
- 239000000932 sedative agent Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 abstract 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 abstract 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 abstract 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 abstract 1
- UOACKFBJUYNSLK-XRKIENNPSA-N Estradiol Cypionate Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H](C4=CC=C(O)C=C4CC3)CC[C@@]21C)C(=O)CCC1CCCC1 UOACKFBJUYNSLK-XRKIENNPSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- RGCVKNLCSQQDEP-UHFFFAOYSA-N Perphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 RGCVKNLCSQQDEP-UHFFFAOYSA-N 0.000 abstract 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 abstract 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 abstract 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 abstract 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 abstract 1
- 229960000571 acetazolamide Drugs 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- OPNPQXLQERQBBV-UHFFFAOYSA-N carbromal Chemical compound CCC(Br)(CC)C(=O)NC(N)=O OPNPQXLQERQBBV-UHFFFAOYSA-N 0.000 abstract 1
- 229960001658 carbromal Drugs 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- TZFWDZFKRBELIQ-UHFFFAOYSA-N chlorzoxazone Chemical compound ClC1=CC=C2OC(O)=NC2=C1 TZFWDZFKRBELIQ-UHFFFAOYSA-N 0.000 abstract 1
- 229960003633 chlorzoxazone Drugs 0.000 abstract 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 abstract 1
- 229960000452 diethylstilbestrol Drugs 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 229940030606 diuretics Drugs 0.000 abstract 1
- -1 elixirs Substances 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- 229930182833 estradiol Natural products 0.000 abstract 1
- 229960005416 estradiol cypionate Drugs 0.000 abstract 1
- 229960001348 estriol Drugs 0.000 abstract 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 abstract 1
- 229940106582 estrogenic substances Drugs 0.000 abstract 1
- 229960003399 estrone Drugs 0.000 abstract 1
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- OUZWUKMCLIBBOG-UHFFFAOYSA-N ethoxzolamide Chemical compound CCOC1=CC=C2N=C(S(N)(=O)=O)SC2=C1 OUZWUKMCLIBBOG-UHFFFAOYSA-N 0.000 abstract 1
- 229950005098 ethoxzolamide Drugs 0.000 abstract 1
- 229960002003 hydrochlorothiazide Drugs 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940035363 muscle relaxants Drugs 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- WBLPIVIXQOFTPQ-UHFFFAOYSA-N oxanamide Chemical compound CCCC1OC1(CC)C(N)=O WBLPIVIXQOFTPQ-UHFFFAOYSA-N 0.000 abstract 1
- 229950005413 oxanamide Drugs 0.000 abstract 1
- CBHCDHNUZWWAPP-UHFFFAOYSA-N pecazine Chemical compound C1N(C)CCCC1CN1C2=CC=CC=C2SC2=CC=CC=C21 CBHCDHNUZWWAPP-UHFFFAOYSA-N 0.000 abstract 1
- 229950007538 pecazine Drugs 0.000 abstract 1
- 229960000762 perphenazine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- HTYIXCKSEQQCJO-UHFFFAOYSA-N phenaglycodol Chemical compound CC(C)(O)C(C)(O)C1=CC=C(Cl)C=C1 HTYIXCKSEQQCJO-UHFFFAOYSA-N 0.000 abstract 1
- 229950005116 phenaglycodol Drugs 0.000 abstract 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 230000001072 progestational effect Effects 0.000 abstract 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 abstract 1
- 229960003147 reserpine Drugs 0.000 abstract 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 abstract 1
- 229960000581 salicylamide Drugs 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/168—Steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises injectable pharmaceutical compositions comprising 6a -methyl-17a - hydroxy - progesterone - 17 - acetate, orally administrable compositions comprising the steroid, a sedative and, optionally, a diuretic, and the steroid and an estrogenic substance and veterinary compositions comprising the steroid and a carrier and, optionally, other therapeutic ingredients. Specified additional therapeutic substances are estrone, estradiol, estriol, ethinyl estradiol, estradiol cyclopentylpropionate and diethylstilbestrol (estrogenic substances); acetyl salicylic acid, N-acetyl-p-aminophenol, salicylamide and phencetin (analgesics); phenobarbitol, carbromal, reserpine and ectyluren (sedatives); ethoxzolamide, hydrochlorthiazide and acetazolamide (diuretics); mepazine, perphenazine and oxanamide (tranquiligus) and corisprodol, chlorzoxazone and phenaglycodol (muscle relaxants). The compositions may be in conventional forms e.g. tablets, capsules, pills, elixirs, suspensions, syrups, mixes with and pre-mixes for addition to animal and bird feed stuffs and may comprise conventional diluents, carriers and excipients. They have progestational activity. Specification 866,381 is referred to.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83290959A | 1959-08-11 | 1959-08-11 | |
US3933360A | 1960-06-28 | 1960-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB953107A true GB953107A (en) | 1964-03-25 |
Family
ID=26716024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB25507/60A Expired GB953107A (en) | 1959-08-11 | 1960-07-21 | Veterinary compositions comprising 6?-methyl-17?-hydroxyprogesterone 17-acetate |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE593957A (en) |
FR (2) | FR169M (en) |
GB (1) | GB953107A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767708B2 (en) | 1998-11-04 | 2010-08-03 | Schering-Plough Animal Health Corp. | Growth stimulant compositions |
-
1960
- 1960-07-21 GB GB25507/60A patent/GB953107A/en not_active Expired
- 1960-08-10 FR FR835562A patent/FR169M/en active Active
- 1960-08-10 BE BE593957A patent/BE593957A/en unknown
- 1960-08-10 FR FR835561A patent/FR168M/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767708B2 (en) | 1998-11-04 | 2010-08-03 | Schering-Plough Animal Health Corp. | Growth stimulant compositions |
US7999005B2 (en) | 1998-11-04 | 2011-08-16 | Schering-Plough Animal Health Corporation | Growth stimulant compositions |
Also Published As
Publication number | Publication date |
---|---|
BE593957A (en) | 1961-02-10 |
FR168M (en) | 1961-02-13 |
FR169M (en) | 1961-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3568828A (en) | Modified sequential oral contraceptive | |
US3409721A (en) | Oral dosage system effective to control the reproduction cycle | |
US20100063019A1 (en) | Low Dose Estrogen Interrupted Hormone Replacement Therapy | |
DE3069013D1 (en) | Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone, their preparation and pharmaceutical compositions containing them | |
US3755575A (en) | Pharmaceutical compositions | |
Emmens | Antifertility agents | |
US2965541A (en) | 17alpha-acetoxyprogesterone compositions for oral use and methods of using same | |
Herman et al. | Oxytetracycline residues in different tissues of trout | |
GORDAN et al. | Methylandrostenediol: a protein-anabolic steroid with little androgenic activity | |
GB953107A (en) | Veterinary compositions comprising 6?-methyl-17?-hydroxyprogesterone 17-acetate | |
Stone | The radioactive compounds in various tissues of the ovariectomised mouse following the systemic administration of tritiated oestradiol and oestrone | |
Morris et al. | Post-coital oral contraception | |
FUENZALIDA | Absorption of steroids from subcutaneously implanted tablets of the pure hormone and of the hormone mixed with cholesterol | |
NZ184731A (en) | Analogues of luteninising hormone releasing factor; pharmaceutical and veterinary compositions | |
US4171358A (en) | Novel contraceptive method | |
Lyon et al. | Duration of sensitivity of the endometrium during lactation in the rat | |
Dorfman et al. | Biological activity of various steroids including B-norsteroids | |
Jackson et al. | Pharmacology of reproduction and fertility | |
Tveter | Distribution of male and female steroid sex hormones in some organs of the male rat | |
Nishino et al. | The sialic acid content in mouse female reproductive organs as a quantitative parameter for testing the estrogenic and antiestrogenic effect, antiestrogenic depot effect, and dissociated effect of estrogens on the uterus and vagina | |
Tyler | Studies of" mini-micro" contraceptive doses of a new progestrogen | |
WU | Gestational effect of allylestrenol | |
GB1459485A (en) | Medicament pack for the oral treatment with oestrogen | |
GB1214712A (en) | Contraceptive preparations | |
ES456094A1 (en) | Analgesic and anti-inflammatory compositions |